Skip to content

Evaluation of negative pressure incisional therapy in urgent gastro-intestinal surgery for reduction of superficial surgical site infections compared to non-occlusive conventional plaster - A prospective, randomized, controlled, multicenter clinical trial

Evaluation of negative pressure incisional therapy in urgent gastro-intestinal surgery for reduction of superficial surgical site infections compared to non-occlusive conventional plaster - A prospective, randomized, controlled, multicenter clinical trial - NEPTUN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00011033
Enrollment
294
Registered
2016-08-30
Start date
2016-09-21
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Comparison of negative pressure incisional therapy with conventional plaster in regard to post-surgical site infections after urgent laparotomies in acute cases of gastro-intestinal disorders.

Interventions

Group 1: After skin closure of laparotomy patients in the experimental intervention receive negative pressure incisional therapy (PREVENA™, KCI Medizinprodukte GmbH, Wiesbaden). The negative pressure

Sponsors

Philipps-Universität Marburg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: •Patients with indication for urgent laparotomy due to an acute gastro-intestinal disorder •age = 18 years •life expectancy > 12 months •Written informed consent of the patient or the patient’s legal representative

Exclusion criteria

Exclusion criteria: •Inpatient treatment longer than 4 days before urgent surgery •Previous transverse or median laparotomy, if it is necessary to reopen it again •Allergy or hypersensitivity against silver or acrylic adhesives •pregnancy •participation in an interventional study with interfering endpoints •neurophysiological deficits

Design outcomes

Primary

MeasureTime frame
Rate of post-surgical site infections of category A1 (superficial) and A2 (deep) within 30 (+7) days after surgery in patients without revision.

Secondary

MeasureTime frame
Prolongation of hospitalisation due to post-surgical site infection, cosmetic result, safety endpoints: AEs, SAEs.

Countries

Germany

Contacts

Public ContactDetlef Bartsch

Klinik für Viszeral-, Thorax- und Gefäßchirurgie Philipps-Universität Marburg

bartsch@med.uni-marburg.de0049 6421-58-66441

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026